Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT00966927
Active, not recruiting Observational

Assessment of Functional Independence and Quality of Life in Adolescents With Spina Bifid

NCT00966927 · tracked via the Priya Life Science Italy tracker
Sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Observational
Started
2021-07-01
Last updated
2025-06-24

Condition(s) studied

Spinal Dysraphism

Study summary

The purpose of this study is to investigate the level of functional independence and the quality of life of adolescents and young adults with spina bifid in an Italian population.

Eligibility

Sex
ALL
Min age
14 Years
Max age
21 Years
Healthy volunteers
No
Inclusion Criteria: * recurrence of clinic control in Unit for Spina Bifid in Parma * 14-21 years old Exclusion Criteria: * subjects unable to understand the items of the questionnaire (mental retardation and need for help at school ) * subjects without any caregiver

Primary outcome measure(s)

  • correlation between the quality of life in adolescents and young adults with Spina Bifid and their level of functional independence — 5 months

Trial sites (1)

FacilityCityRegionStatus
Unit for Care of Spina Bifida Parma Parma

More Azienda USL Reggio Emilia - IRCCS trials in Italy

Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study Active, not recruiting
Tomosynthesis as Primary Test for Breast Cancer Screening Active, not recruiting
Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Qualitative Study Recruiting
Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD Recruiting
Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT00966927 on ClinicalTrials.gov ↗ ← All trials in Italy